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Introduction
Cryopyrin-associated periodic syndrome (CAPS), clini-
cally characterized by neutrophil-rich urticarial rash, is
associated with missense mutations in NLRP3. NLRP3 is
a pattern recognition receptor in the cytoplasm of cells
and structurally related to plant resistance proteins,
which detect pathogen- or danger-associated signals,
leading to programmed cell death and hyper response at
the local site in plants. In mammals, activated NLRP3
forms inflammasome, which orchestrates the early
inflammatory process via IL-1b activation, and also cause
programmed necrotic cell death termed “pyronecrosis”.
However, the mechanistic details are largely unknown.
Objectives
To investigate the mechanism of NLRP3-mediated pyro-
necrosis and its in vivo relevance.
Methods
We have established a system in which pyronecrosis was
induced by the expression of CAPS-associated gain-of-
function mutant of NLRP3, using a tetracycline-inducible
expression (Tet-on) system. We also induced NLRP3-
mediated cell death in mouse air-pouch and harvested the
cells and fluid.
Results
Mutant NLRP3 expression without LPS pretreatment
induced only necrotic cell death but not IL-1b secretion in
this system. Silencing ASC gene by shRNA prevented pyr-
onecrosis, while silencing caspase-1 did not. When the cell
lines expressing NLRP3 mutants by Tet-on system were
treated with cathesin B inhibitor, necrotic cell death and
speckle patterns of ASC oligomerization were not
observed. Interestingly, when these cells were treated with
Z-VAD-fmk, the speckle patterns of ASC were seen while
they were still alive.
Upon oral administration of doxycycline, injection of
LPS-pretreated NLRP3-mutant cells into mouse air-
pouch showed necrotic cell death in addition to IL-1b
release, resulting in the significant increase in numbers of
neutrophils in the pouch. Interestingly, non-pretreated
mutant cells, which showed necrotic cell death without
mature IL-1b release, also induced neutrophil infiltration,
though smaller in number relative to neutrophil infiltra-
tion induced by LPS-pretreated mutant cells.
Conclusion
Pyronecrosis is provoked by downstream of NLRP3-
induced ASC oligomerization, but does not require
caspase-1 or IL-1b cleavage, and that cathesin B inhibitor
and Z-VAD-fmk inhibit pyronecrosis before and after
ASC oligomerization, respectively. This clarify the differ-
ences of pyronecrosis from pyroptosis which is mediated
by ASC oligomerization but do not require NLRP3. In
vivo study showed that necrotic cell death by pyronecrosis
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